Adaptive Phage Therapeutics

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.

Health and bio

TIMELINE · MONEY RAISED

Adaptive Phage Therapeutics | 2021 days on the record

Raised $85M in 3 sourced rounds

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

1. June 13, 2023
   Series B+ · $24M
   AAMR Action Fund (lead), DDeerfield (lead)
   Source: startupintros.com
2. April 4, 2022
   Series B+ · $20M
   AAMR Action Fund (lead)
   Source: startupintros.com
3. May 1, 2021
   Series B+ · $41M
   DDeerfield (lead), MMayo Clinic
   Source: startupintros.com
4. September 23, 2016
   Website created

Founders and team

• CM
  Carl Merril Founder

  LinkedIn
• GM
  Greg Merril Founder

  @gregmerril · LinkedIn
• EF
  Edward Fang Chief Medical Officer
• MK
  Michael King Chief Business Officer
• MW
  Michele Wales Chief Legal Officer
• MB
  Miguel Barreto Principal Scientist

Investors

• AAlexandria Venture Investments
• AAMR Action Fundlead investor
• DDeerfieldlead investor
• DDefense Health Agency
• MMayo Clinic
• UU.S. Department of War

Companies like Adaptive Phage Therapeutics

• SsmartbaxSeed · Jun 2026
• OOmnix Medical$25M Series B+ · Oct 2025
• HHolobiomeSeed · Jul 2026
• AAdcytherixSeries A · Oct 2025
• SSFA TherapeuticsSeed · Jun 2022
• VVedanta Biosciences$60M Series B+ · Aug 2026

Other companies backed by AMR Action Fund

• VVedanta Biosciences$60M Series B+ · Aug 2026
• PPeptilogics$78M Series B+ · Oct 2025
• FF2G$100M Series B+ · Sep 2024

AMR Action Fund portfolio →